FDA NDC Directory · JSON-LD · Markdown

DOXIL

NDC 0338-9667 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION, LIPOSOMAL

Generic namedoxorubicin hydrochloride
Labeler / ManufacturerBaxter Healthcare Corporation
Marketing categoryNew Drug Application (innovator) · App NDA050718
Dosage form / routeINJECTION, SUSPENSION, LIPOSOMAL · INTRAVENOUS
Active ingredientsDOXORUBICIN HYDROCHLORIDE (2 mg/mL)
Marketing started20240826
Package count1

External sources

Source: openFDA. Public-domain (CC0).